Small caps round-up: Green Compliance, Deltex Medical, Mouchel...

Green Compliance, an AIM-listed provider of business support services, has reported a solid trading outcome for the year ended March 31st, in line with its expectations. The firm said that while it has not been immune to declines in the UK economy, is has won businesses and contracts throughout the year, with the bid pipeline remaining "robust".

Deltex Medical Group has posted positive results of the first randomised controlled clinical trial of the effect of using CardioQ-ODM during emergency abdominal surgery. The product showed that 48% of patients experienced a reduction in cardiovascular complications, 73% in surgical site infections, and 62% in kidney complaints. There was also a 25% reduction on the average length of hospital stays.

Mouchel Group, the infrastructure and business services group, reported unchanged revenue of £270m for the half year ended January 2012 compared to the same period the previous year. Loss before tax widened significantly from £1.5m to £11.6m. "The market in the UK is likely to remain flat in the short term and we don't envisage a step change in growth within the next 12 to 18 months," the firm said, although it added that "2012 is a year of transition for Mouchel". Basic earnings per share showed a loss of 11.3p (2011: loss 1.1p).

Try 6 free issues of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Sign up

Motive Television reported a £0.7m rise in revenue to £2m, but revealed a widening of losses from £2.48m to £2.54m after cost of sales rose and financial costs soared. Cash levels dropped from £1.3m to £0.56m. Loss per share was 0.15p (2010: 0.39p). "While Motive is confident about closing important sales that were initiated and progressed during 2011, until the business environment becomes more positive it will remain challenging for any B2B provider to gain firm commitments," the company said.